Large-scale study of Toxoplasma and Cytomegalovirus shows an association between infection and serious psychiatric disorders

Brain, Behavior, and Immunity

Volumn 79, Issue , 2019, Pages 152-158

  Burgdorf, Kristoffer Sølvsten ^a   Trabjerg, Betina B ^b,c   Pedersen, Marianne Giørtz ^b,c   Nissen, Janna ^a   Banasik, Karina ^d   Pedersen, Ole Birger ^e   Sørensen, Erik ^a   Nielsen, Kaspar René ^f   Larsen, Margit Hørup ^a   Erikstrup, Christian ^g   Bruun Rasmussen, Peter ^d   Westergaard, David ^d   Thørner, Lise Wegner ^a   Hjalgrim, Henrik ^a,h   Paarup, Helene Martina ⁱ   Brunak, Søren ^d   Pedersen, Carsten B ^b,c   Torrey, E Fuller ^j   Werge, Thomas ^c,k   Mortensen, Preben Bo ^b,c   Yolken, Robert H ^l   Ullum, Henrik ^a   more..

^a University of Copenhagen   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c iPSYCH   (Denmark)

^d University of Copenhagen   (Denmark)

^e NAESTVED HOSPITAL   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h STATENS SERUM INSTITUT   (Denmark)

ⁱ ODENSE UNIVERSITY HOSPITAL   (Denmark)

^j The Stanley Medical Research Institute   (United States)

^k Mental Health Center Glostrup   (Denmark)

^l JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

Antibodies; Cytomegalovirus; Infection; Parasite, psychiatric disorders; Serology; Suicide; Toxoplasma gondii; Toxoplasmosis; Traffic accidents

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DANISH CITIZEN; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOOD DISORDER; NEUROSIS; NONHUMAN; PARASITE IDENTIFICATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SOMATOFORM DISORDER; STRESS; SUICIDE; SUICIDE ATTEMPT; TOXOPLASMA GONDII; TOXOPLASMOSIS; TRAFFIC ACCIDENT; VIRUS DETECTION; ADOLESCENT; BLOOD; DENMARK; EPIDEMIOLOGY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; ODDS RATIO; PATHOGENICITY; RISK FACTOR; TOXOPLASMA;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; DENMARK; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MENTAL DISORDERS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SCHIZOPHRENIA; SUICIDE, ATTEMPTED; SUICIDE, COMPLETED; TOXOPLASMA; TOXOPLASMOSIS;

EID: 85061158198     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2019.01.026     Document Type: Article

References (70)

1. Alvarado-Esquivel, C., Torres-Castorena, A., Liesenfeld, O., Estrada-Martínez, S., Urbina-Álvarez, J.D., High seroprevalence of Toxoplasma gondii infection in a subset of Mexican patients with work accidents and low socioeconomic status. Parasites Vect., 5, 2012, 13, 10.1186/1756-3305-5-13.
2. Bosch, J.A., Rector, J.L., Turner, J.E., Riddell, N.E., O'Hartaigh, B., Burns, V.E., Psychoneuromicrobiology: cytomegalovirus infection as a putative link between stress, aging, and immunity. Immunosenescence, 2013, Springer New York, New York, NY, 81–100, 10.1007/978-1-4614-4776-4_6.
3. Burgdorf, K.S., Simonsen, J., Sundby, A., Rostgaard, K., Pedersen, O.B., Sørensen, E., Nielsen, K.R., Bruun, M.T., Frisch, M., Edgren, G., Erikstrup, C., Hjalgrim, H., Ullum, H., Socio-demographic characteristics of Danish blood donors. PLoS ONE, 12, 2017, e0169112, 10.1371/journal.pone.0169112.
4. Campbell, B.M., Charych, E., Lee, A.W., Möller, T., Kynurenines in CNS disease: regulation by inflammatory cytokines. Front. Neurosci., 8, 2014, 10.3389/fnins.2014.00012.
5. Dean, K., Stevens, H., Mortensen, P.B., Murray, R.M., Walsh, E., Pedersen, C.B., Full spectrum of psychiatric outcomes among offspring with parental history of mental disorder. Arch. Gen. Psychiatry, 67, 2010, 822, 10.1001/archgenpsychiatry.2010.86.
6. Dickerson, F., Boronow, J., Stallings, C., Origoni, A., Yolken, R., Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophr. Bull. 33 (2007), 737–740, 10.1093/schbul/sbm005.
7. Dickerson, F., Origoni, A., Schweinfurth, L.A.B., Stallings, C., Savage, C.L.G., Sweeney, K., Katsafanas, E., Wilcox, H.C., Khushalani, S., Yolken, R., Clinical and serological predictors of suicide in schizophrenia and major mood disorders. J. Nerv. Ment. Dis. 206 (2018), 173–178, 10.1097/NMD.0000000000000772.
8. Dickerson, F., Stallings, C., Origoni, A., Katsafanas, E., Schweinfurth, L., Savage, C., Khushalani, S., Yolken, R., Antibodies to toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. J. Nerv. Ment. Dis. 202 (2014), 589–593, 10.1097/NMD.0000000000000166.
9. Dickerson, F., Stallings, C., Origoni, A., Katsafanas, E., Schweinfurth, L.A.B., Savage, C.L.G., Yolken, R., Association between cytomegalovirus antibody levels and cognitive functioning in non-elderly adults. PLoS ONE, 9, 2014, e95510, 10.1371/journal.pone.0095510.
10. Dickerson, F., Wilcox, H.C., Adamos, M., Katsafans, E., Khushalani, S., Origoni, A., Savage, C., SChweinfurth, L., Stallings, C., Sweeney, K., Yolken, R., Suicide attempts and markers of immune response in individuals with serious mental illness. J. Psychiatr. Res. 87 (2017), 37–43, 10.1016/j.jpsychires.2016.11.011.
11. Dickerson, F.B., Boronow, J.J., Stallings, C., Origoni, A.E., Ruslanova, I., Yolken, R.H., Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch. Gen. Psychiatry 60 (2003), 466–472, 10.1001/archpsyc.60.5.466.
12. Dollard, S.C., Grosse, S.D., Ross, D.S., New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev. Med. Virol. 17 (2007), 355–363, 10.1002/rmv.544.
13. El-Defrawy, S.R., Boegman, R.J., Jhamandas, K., Beninger, R.J., The neurotoxic actions of quinolinic acid in the central nervous system. Can. J. Physiol. Pharmacol. 64 (1986), 369–375, 10.1139/y86-060.
14. Eyles, D., Feldon, J., Meyer, U., Schizophrenia: do all roads lead to dopamine or is this where they start Evidence from two epidemiologically informed developmental rodent models. Transl. Psychiatry 2 (2012), e81–e110, 10.1038/tp.2012.6.
15. Ferreira, E.C., Marchioro, A.A., Guedes, T.A., Mota, D.C.G.A., Guilherme, A.L.F., de Araujo, S.M., Association between seropositivity for Toxoplasma gondii, scholastic development of children and risk factors for T. gondii infection. Trans. R. Soc. Trop. Med. Hyg. 107 (2013), 390–396, 10.1093/trstmh/trt026.
16. Flegr, J., Dama, M., Does the prevalence of latent toxoplasmosis and frequency of Rhesus-negative subjects correlate with the nationwide rate of traffic accidents?. Folia Parasitol. (Praha) 61 (2014), 485–494 https://doi.org/10.14411/fp.2014.061.
17. Flegr, J., Havlícek, J., Kodym, P., Malý, M., Smahel, Z., Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis., 2, 2002, 11, 10.1186/1471-2334-2-11.
18. Flegr, J., Horáček, J., Toxoplasmosis, but not borreliosis, is associated with psychiatric disorders and symptoms. Schizophr. Res., 0–1, 2018, 10.1016/j.schres.2018.02.008.
19. Flegr, J., Klose, J., Novotná, M., Berenreitterová, M., Havlíček, J., Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect. Dis., 9, 2009, 72, 10.1186/1471-2334-9-72.
20. Flegr, J., Lenochová, P., Hodný, Z., Vondrová, M., Fatal attraction phenomenon in humans – Cat odour attractiveness increased for Toxoplasma-infected men while decreased for infected women. PLoS Negl. Trop. Dis., 5, 2011, 10.1371/journal.pntd.0001389.
21. Flegr, J., Preiss, M., Klose, J., Havlı́ček, J., Vitáková, M., Kodym, P., Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis?. Biol. Psychol. 63 (2003), 253–268, 10.1016/S0301-0511(03)00075-9.
22. Gajewski, P.D., Falkenstein, M., Hengstler, J.G., Golka, K., Toxoplasma gondii impairs memory in infected seniors. Brain. Behav. Immun. 36 (2014), 193–199, 10.1016/j.bbi.2013.11.019.
23. Gaskell, E.A., Smith, J.E., Pinney, J.W., Westhead, D.R., McConkey, G.A., A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS ONE 4 (2009), 1–10, 10.1371/journal.pone.0004801.
24. Glaser, R., Kiecolt-Glaser, J.K., Stress-associated immune modulation and its implications for reactivation of latent herpesviruses. Infect. Dis. Ther. Ser. 13:1 (1994), 245–270.
25. Gohardehi, S., Sharif, M., Sarvi, S., Moosazadeh, M., Alizadeh-Navaei, R., Hosseini, S.A., Amouei, A., Pagheh, A., Sadeghi, M., Daryani, A., The potential risk of toxoplasmosis for traffic accidents: a systematic review and meta-analysis. Exp. Parasitol. 191 (2018), 19–24, 10.1016/j.exppara.2018.06.003.
26. Gutiérrez-Fernández, J., Luna del Castillo, J.D., Carrillo-Ávila, J.A., Gutiérrez, B., Cervilla, J., Sorlózano-Puerto, A., Mañanes-González, S.,. Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study. Neuropsychiatr. Dis. Treat. 11 (2015), 843–852, 10.2147/NDT.S79285.
27. Hamdani, N., Daban-Huard, C., Godin, O., Laouamri, H., Jamain, S., Attiba, D., Delavest, M., Lépine, J.-P., Le Corvoisier, P., Houenou, J., Richard, J.-R., Yolken, R.H., Krishnamoorthy, R., Tamouza, R., Leboyer, M., Dickerson, F.B., Effects of cumulative herpesviridae and toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects. J. Clin. Psychiatry 78 (2017), e18–e27, 10.4088/JCP.15m10133.
28. Henriquez, S.A., Brett, R., Alexander, J., Pratt, J., Roberts, C.W., neuropsychiatric disease and toxoplasma gondii infection. NeuroImmunoModulat. 16 (2009), 122–133, 10.1159/000180267.
29. Johnson, S.K., Fitza, M.A., Lerner, D.A., Calhoun, D.M., Beldon, M.A., Chan, E.T., Johnson, P.T.J., Risky business: linking toxoplasma gondii infection and entrepreneurship behaviours across individuals and countries. Proc. R. Soc. B Biol. Sci., 285, 2018, 20180822, 10.1098/rspb.2018.0822.
30. Juel, K., Helweg-Larsen, K., The Danish registers of causes of death. Dan Med Bull. 46 (1999), 354–357.
31. Kessler, M., Terramani, T., Lynch, G., Baudry, M., A glycine site associated with n-methyl-d-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52 (1989), 1319–1328, 10.1111/j.1471-4159.1989.tb01881.x.
32. Khandaker, G.M., Dalman, C., Kappelmann, N., Stochl, J., Dal, H., Kosidou, K., Jones, P.B., Karlsson, H., Association of childhood infection with IQ and adult nonaffective psychosis in Swedish men a population-based longitudinal cohort and co-relative study. JAMA Psychiatry 75 (2018), 356–362, 10.1001/jamapsychiatry.2017.4491.
33. Khandaker, G.M., Zimbron, J., Lewis, G., Jones, P.B., Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol. Med. 43 (2013), 239–257, 10.1017/S0033291712000736.
34. Kuo, C.-P., Wu, C.-L., Ho, H.-T., Chen, C.G., Liu, S.-I., Lu, Y.-T., Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy. Clin. Microbiol. Infect. 14 (2008), 221–227, 10.1111/j.1469-0691.2007.01895.x.
35. Lanchava, L., Carlson, K., Šebánková, B., Flegr, J., Nave, G., No evidence of association between Toxoplasma gondii infection and financial risk taking in females. PLoS ONE 10 (2015), 1–17, 10.1371/journal.pone.0136716.
36. Leweke, F.M., Gerth, C.W., Koethe, D., Klosterkötter, J., Ruslanova, I., Krivogorsky, B., Torrey, E.F., Yolken, R.H., Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 254 (2004), 4–8, 10.1007/s00406-004-0481-6.
37. Lynge, E., Sandegaard, J.L., Rebolj, M., The Danish national patient register. Scand. J. Public Health 39 (2011), 30–33, 10.1177/1403494811401482.
38. Martin, H.L., Alsaady, I., Howell, G., Prandovszky, E., Peers, C., Robinson, P., McConkey, G.A., Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells. Neuroscience 306 (2015), 50–62, 10.1016/j.neuroscience.2015.08.005.
39. McConkey, G.A., Martin, H.L., Bristow, G.C., Webster, J.P., Toxoplasma gondii infection and behaviour – Location, location, location?. J. Exp. Biol. 216 (2013), 113–119, 10.1242/jeb.074153.
40. Mendy, A., Vieira, E.R., Albatineh, A.N., Gasana, J., Toxoplasma gondii seropositivity and cognitive functions in school-aged children. Parasitology 142 (2015), 1221–1227, 10.1017/S0031182015000505.
41. Mendy, A., Vieira, E.R., Albatineh, A.N., Gasana, J., Immediate rather than delayed memory impairment in older adults with latent toxoplasmosis. Brain. Behav. Immun. 45 (2015), 36–40, 10.1016/j.bbi.2014.12.006.
42. Mors, O., Perto, G.P., Mortensen, P.B., The Danish psychiatric central research register. Scand. J. Public Health 39 (2011), 54–57, 10.1177/1403494810395825.
43. Nagineni, C.N., Pardhasaradhi, K., Martins, M.C., Detrick, B., Hooks, J.J., Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun. 64 (1996), 4188–4196.
44. Nimgaonkar, V.L., Yolken, R.H., Wang, T., Chang, C.-C.H., McClain, L., McDade, E., Snitz, B.E., Ganguli, M., Temporal cognitive decline associated with exposure to infectious agents in a population-based aging cohort. Alzheimer Dis. Assoc. Disord. 30 (2016), 216–222, 10.1097/WAD.0000000000000133.
45. Nissen, J., Jokelainen, P., Stensvold, C.R., Trevisan, C., Fuchs, J., Burgdorf, K.S., Nielsen, H.V., Pires, S.M., The disease burden of congenital toxoplasmosis in Denmark, 2014. PLoS ONE, 12, 2017, e0178282, 10.1371/journal.pone.0178282.
46. Nordentoft, M., Absolute risk of suicide after first hospital contact in mental disorder. Arch. Gen. Psychiatry, 68, 2011, 1058, 10.1001/archgenpsychiatry.2011.113.
47. Pandey, G.N., Rizavi, H.S., Ren, X., Bhaumik, R., Dwivedi, Y., Toll-like receptors in the depressed and suicide brain. J. Psychiatry Res. 53 (2014), 62–68, 10.1016/j.jpsychires.2014.01.021.
48. Pearce, N., What does the odds ratio estimate in a case-control study?. Int. J. Epidemiol. 22 (1993), 1189–1192.
49. Pedersen, C.B., Mors, O., Bertelsen, A., Waltoft, B.L., Agerbo, E., McGrath, J.J., Mortensen, P.B., Eaton, W.W., A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry, 71, 2014, 573, 10.1001/jamapsychiatry.2014.16.
50. Pedersen, M.G., Stevens, H., Pedersen, C.B., Nørgaard-Pedersen, B., Mortensen, P.B., Toxoplasma infection and later development of schizophrenia in mothers. Am. J. Psychiatry 168 (2011), 814–821, 10.1176/appi.ajp.2011.10091351.
51. Phillips, A.C., Carroll, D., Khan, N., Moss, P., Cytomegalovirus is associated with depression and anxiety in older adults. Brain. Behav. Immun. 22 (2008), 52–55, 10.1016/j.bbi.2007.06.012.
52. Poirotte, C., Kappeler, P.M., Ngoubangoye, B., Bourgeois, S., Moussodji, M., Charpentier, M.J.E., Morbid attraction to leopard urine in toxoplasma-infected chimpanzees. Curr. Biol. 26 (2016), R98–R99, 10.1016/j.cub.2015.12.020.
53. Prandovszky, E., Gaskell, E., Martin, H., Dubey, J.P., Webster, J.P., McConkey, G.A., The neurotropic parasite toxoplasma gondii increases dopamine metabolism. PLoS ONE, 6, 2011, 10.1371/journal.pone.0023866.
54. Prossin, A.R., Yolken, R.H., Kamali, M., Heitzeg, M.M., Kaplow, J.B., Coryell, W.H., McInnis, M.G., Cytomegalovirus antibody elevation in bipolar disorder: Relation to elevated mood states. Neural Plast., 2015, 2015, 10.1155/2015/939780.
55. Rector, J.L., Dowd, J.B., Loerbroks, A., Burns, V.E., Moss, P.A., Jarczok, M.N., Stalder, T., Hoffman, K., Fischer, J.E., Bosch, J.A., Consistent associations between measures of psychological stress and CMV antibody levels in a large occupational sample. Brain. Behav. Immun. 38 (2014), 133–141, 10.1016/j.bbi.2014.01.012.
56. Rothman, J.K., Greenland, S., Lash, T., Modern Epidemiology. 3th ed., 2008, Lippincott Williams & Wilking, Philadelphia.
57. Sever, J.L., Ellenberg, J.H., Ley, A.C., Madden, D.L., Fuccillo, D.A., Tzan, N.R., Edmonds, D.M., Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies. Pediatrics 82 (1988), 181–192.
58. Skallová, A., Novotná, M., Kolbeková, P., Gašová, Z., Veselý, V., Sechovská, M., Flegr, J., Decreased level of novelty seeking in blood donors infected with toxoplasma. Neuroendocrinol. Lett. 26 (2005), 480–486.
59. Stepanova, E.V., Kondrashin, A.V., Sergiev, V.P., Morozova, L.F., Turbabina, N.A., Maksimova, M.S., Brazhnikov, A.I., Shevchenko, S.B., Morozov, E.N., Significance of chronic toxoplasmosis in epidemiology of road traffic accidents in Russian Federation. PLoS ONE, 12, 2017, e0184930, 10.1371/journal.pone.0184930.
60. Sutterland, A.L., Fond, G., Kuin, A., Koeter, M.W.J.J., Lutter, R., van Gool, T., Yolken, R., Szoke, A., Leboyer, M., de Haan, L., Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: Systematic review and meta-analysis. Acta Psychiatry Scand. 132 (2015), 161–179, 10.1111/acps.12423.
61. Tanaka, T., Matsuda, T., Hayes, L.N., Yang, S., Rodriguez, K., Severance, E.G., Yolken, R.H., Sawa, A., Eaton, W.W., Infection and inflammation in schizophrenia and bipolar disorder. Neurosci. Res. 115 (2017), 59–63, 10.1016/j.neures.2016.11.002.
62. Torrey, E.F., Bartko, J.J., Lun, Z.R., Yolken, R.H., Antibodies to toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 33 (2007), 729–736, 10.1093/schbul/sbl050.
63. Torrey, E.F., Bartko, J.J., Yolken, R.H., Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 38 (2012), 642–647, 10.1093/schbul/sbs043.
64. Trzonkowski, P., Myśliwska, J., Godlewska, B., Szmit, E., Łukaszuk, K., Więckiewicz, J., Brydak, L., Machała, M., Landowski, J., Myśliwski, A., Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients. Brain. Behav. Immun. 18 (2004), 135–148, 10.1016/S0889-1591(03)00111-9.
65. van Zanten, J., Harmsen, M.C., van der Giessen, M., van der Bij, W., Prop, J., de Leij, L., The, T.H., Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins. Clin. Diagn. Lab. Immunol. 2 (1995), 214–218.
66. Vandenbroucke, J.P., Pearce, N., Case-control studies: basic concepts. Int. J. Epidemiol. 41 (2012), 1480–1489, 10.1093/ije/dys147.
67. WHO, WHO ICD- 10: Mental and Behavioural Disorders, Classification and. 1994, Diagnostic Criteria.
68. WHO, 1965. Classification of Diseases: Extended Danish-Latin Version of the World Health Organization International Classification of Diseases, 8th Revision.
69. Worth, A.R., Andrew Thompson, R.C., Lymbery, A.J., Reevaluating the evidence for toxoplasma gondii-induced behavioural changes in rodents. Adv. Parasitol., 2014, 10.1016/B978-0-12-800182-0.00003-9.
70. Wyman, C.P., Gale, S.D., Hedges-Muncy, A., Erickson, L.D., Wilson, E., Hedges, D.W., Association between Toxoplasma gondii seropositivity and memory function in nondemented older adults. Neurobiol. Aging 53 (2017), 76–82, 10.1016/j.neurobiolaging.2017.01.018.